Literature DB >> 34987796

Lack of association between C282Y and H63D polymorphisms in the hemochromatosis gene and risk of multiple sclerosis: A meta-analysis.

Nada Starčević Čizmarević1, Božena Ćurko-Cofek2, Vesna Barac-Latas2, Borut Peterlin3, Smiljana Ristić1.   

Abstract

Increasing evidence supports the potential role of iron metabolism in multiple sclerosis (MS). Previous studies examining the association between polymorphisms of the hemochromatosis gene (HFE) and susceptibility to MS have yielded inconsistent results. In the present study, a meta-analysis of 7 studies was performed conducted in populations of Caucasian origin using the Comprehensive Meta-analysis 3.0 software. The strength of association between the C282Y and H63D polymorphisms in HFE and MS risk was estimated by odds ratios with 95% confidence intervals. Cochran's Q statistic and I2 tests were applied to quantify heterogeneity between studies. An Egger's test was used to estimate publication bias. The C282Y and H63D polymorphisms had no significant association with increased MS risk (all P≥0.05) in the following genetic comparison models: Dominant model (YY + CY vs. CC or DD + HD vs. HH) and allele contrast (Y vs. C or D vs. H). No apparent publication bias or significant heterogeneity was found between studies. These results suggest that the HFE polymorphisms C282Y and H63D are not associated with susceptibility to MS in populations of Caucasian origin. Further studies should be performed in a larger series of MS patients to evaluate the contribution of HFE and other genetic variants associated with iron regulation in the development and progression of MS.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  C282Y; H63D; HFE; iron; meta-analysis; multiple sclerosis

Year:  2021        PMID: 34987796      PMCID: PMC8719312          DOI: 10.3892/br.2021.1495

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  29 in total

1.  Prevalence of HFE gene C282Y and H63D mutations in a French-Canadian population of neonates and in referred patients.

Authors:  Joël Girouard; Yves Giguère; Robert Delage; François Rousseau
Journal:  Hum Mol Genet       Date:  2002-01-15       Impact factor: 6.150

Review 2.  Multiple sclerosis - a review.

Authors:  R Dobson; G Giovannoni
Journal:  Eur J Neurol       Date:  2018-11-18       Impact factor: 6.089

3.  Lack of clinical manifestation of hereditary haemochromatosis in South African patients with multiple sclerosis.

Authors:  Maritha J Kotze; J Nico P de Villiers; Louise Warnich; Stephen Schmidt; Jonathan Carr; Erna Mansvelt; Elba Fourie; Susan J van Rensburg
Journal:  Metab Brain Dis       Date:  2006-07-19       Impact factor: 3.584

4.  Hemochromatosis and iron-overload screening in a racially diverse population.

Authors:  Paul C Adams; David M Reboussin; James C Barton; Christine E McLaren; John H Eckfeldt; Gordon D McLaren; Fitzroy W Dawkins; Ronald T Acton; Emily L Harris; Victor R Gordeuk; Catherine Leiendecker-Foster; Mark Speechley; Beverly M Snively; Joan L Holup; Elizabeth Thomson; Phyliss Sholinsky
Journal:  N Engl J Med       Date:  2005-04-28       Impact factor: 91.245

Review 5.  Iron, brain ageing and neurodegenerative disorders.

Authors:  Luigi Zecca; Moussa B H Youdim; Peter Riederer; James R Connor; Robert R Crichton
Journal:  Nat Rev Neurosci       Date:  2004-11       Impact factor: 34.870

6.  Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis.

Authors:  Sreeram V Ramagopalan; Marko Cukjati; Maja Cernilec; Gabriele C DeLuca; David A Dyment; Alexandra Degenhardt; A Dessa Sadovnick; Vladka Curin Serbec; George C Ebers; Pierre Duquette
Journal:  J Neuroimmunol       Date:  2008-10-15       Impact factor: 3.478

7.  Brain Iron at Quantitative MRI Is Associated with Disability in Multiple Sclerosis.

Authors:  Robert Zivadinov; Eleonora Tavazzi; Niels Bergsland; Jesper Hagemeier; Fuchun Lin; Michael G Dwyer; Ellen Carl; Channa Kolb; David Hojnacki; Deepa Ramasamy; Jacqueline Durfee; Bianca Weinstock-Guttman; Ferdinand Schweser
Journal:  Radiology       Date:  2018-07-17       Impact factor: 11.105

8.  Gray matter SWI-filtered phase and atrophy are linked to disability in MS.

Authors:  Jesper Hagemeier; Bianca Weinstock-Guttman; Mari Heininen-Brown; Guy U Poloni; Niels Bergsland; Claudiu Schirda; Christopher R Magnano; Cheryl Kennedy; Ellen Carl; Michael G Dwyer; Alireza Minagar; Robert Zivadinov
Journal:  Front Biosci (Elite Ed)       Date:  2013-01-01

Review 9.  Pathophysiological consequences and benefits of HFE mutations: 20 years of research.

Authors:  Ina Hollerer; André Bachmann; Martina U Muckenthaler
Journal:  Haematologica       Date:  2017-03-09       Impact factor: 9.941

Review 10.  The Interaction between Viral and Environmental Risk Factors in the Pathogenesis of Multiple Sclerosis.

Authors:  Rachael Eugenie Tarlinton; Timur Khaibullin; Evgenii Granatov; Ekaterina Martynova; Albert Rizvanov; Svetlana Khaiboullina
Journal:  Int J Mol Sci       Date:  2019-01-14       Impact factor: 5.923

View more
  1 in total

Review 1.  An Update on Diagnostic Laboratory Biomarkers for Multiple Sclerosis.

Authors:  Marwa Kaisey; Ghazal Lashgari; Justyna Fert-Bober; Daniel Ontaneda; Andrew J Solomon; Nancy L Sicotte
Journal:  Curr Neurol Neurosci Rep       Date:  2022-10-21       Impact factor: 6.030

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.